Pure Global

Epstein-Barr Virus IgG - India CDSCO Medical Device Registration

Epstein-Barr Virus IgG is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001078_53b8937231ea052a8b3ddd1a81841888_6f03a515faeeaa66023b093775f28161. This device is marketed under the brand name NovaLisa®. The license holder is OSB Agencies Private Limiated, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Epstein-Barr Virus IgG
UID: IMP/IVD/2020/001078_53b8937231ea052a8b3ddd1a81841888_6f03a515faeeaa66023b093775f28161

Brand Name

NovaLisa®

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Epstein-Barr Virus (NovaLisa®) IgG ELISA is intended for the qualitative determination of IgG class antibodies against Epstein-Barr Virus viral capsid antigen (NovaLisa®) in human serum or plasma (NovaLisa®)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing